AU2003292720A1 - Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same - Google Patents

Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same

Info

Publication number
AU2003292720A1
AU2003292720A1 AU2003292720A AU2003292720A AU2003292720A1 AU 2003292720 A1 AU2003292720 A1 AU 2003292720A1 AU 2003292720 A AU2003292720 A AU 2003292720A AU 2003292720 A AU2003292720 A AU 2003292720A AU 2003292720 A1 AU2003292720 A1 AU 2003292720A1
Authority
AU
Australia
Prior art keywords
dihydrothienoquinoline
derivatives
same
cell adhesion
adhesion inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003292720A
Other versions
AU2003292720A8 (en
Inventor
Munetada Haruyama
Reiko Kamei
Kenji Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Publication of AU2003292720A8 publication Critical patent/AU2003292720A8/en
Publication of AU2003292720A1 publication Critical patent/AU2003292720A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU2003292720A 2002-12-26 2003-12-26 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same Abandoned AU2003292720A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002378087A JP2006151810A (en) 2002-12-26 2002-12-26 Dihydrothienoquinoline derivative and cell adhesion inhibitor containing the same
JP2002-378087 2002-12-26
PCT/JP2003/017063 WO2004058772A1 (en) 2002-12-26 2003-12-26 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same

Publications (2)

Publication Number Publication Date
AU2003292720A8 AU2003292720A8 (en) 2004-07-22
AU2003292720A1 true AU2003292720A1 (en) 2004-07-22

Family

ID=32677415

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003292720A Abandoned AU2003292720A1 (en) 2002-12-26 2003-12-26 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same

Country Status (3)

Country Link
JP (1) JP2006151810A (en)
AU (1) AU2003292720A1 (en)
WO (1) WO2004058772A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10092574B2 (en) 2012-09-26 2018-10-09 Valorisation-Recherche, Limited Partnership Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200634019A (en) * 2004-12-21 2006-10-01 Wyeth Corp Thienoisoquinoline-phenylsulfonamides and their use as er-nfkb inhibitors
UY30377A1 (en) * 2006-06-02 2008-01-02 Elan Pharm Inc FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA
CA2682733A1 (en) * 2007-04-13 2008-10-23 Supergen, Inc. Axl kinase inhibitors
CL2009000429A1 (en) * 2008-02-26 2009-09-25 Takeda Pharmaceuticals Co Compounds derived from fused carbamoyl-heterocycles, especially pyrrolo [3,2-c] pyridine-2-carboxamides, smo inhibitors; pharmaceutical composition comprising said compounds; and use in the prophylaxis or treatment of cancer.
WO2013013188A1 (en) 2011-07-21 2013-01-24 Tolero Pharmaceuticals, Inc. Heterocyclic protein kinase inhibitors
CN112533602A (en) 2018-04-05 2021-03-19 大日本住友制药肿瘤公司 AXL kinase inhibitors and uses thereof
CN108623613A (en) * 2018-04-24 2018-10-09 哈尔滨工业大学（威海） A kind of preparation method and application of nitrogenous, sulphur fused ring compound
MX2021009371A (en) 2019-02-12 2021-09-10 Sumitomo Pharma Oncology Inc Formulations comprising heterocyclic protein kinase inhibitors.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8504702D0 (en) * 1985-02-23 1985-03-27 Zyma Sa Tricyclic compounds
JP2997828B2 (en) * 1992-07-30 2000-01-11 株式会社大塚製薬工場 Quinoline and naphthyridine derivatives
WO2001045680A2 (en) * 1999-12-21 2001-06-28 Astrazeneca Ab Cd45 inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10092574B2 (en) 2012-09-26 2018-10-09 Valorisation-Recherche, Limited Partnership Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof

Also Published As

Publication number Publication date
AU2003292720A8 (en) 2004-07-22
WO2004058772A1 (en) 2004-07-15
JP2006151810A (en) 2006-06-15

Similar Documents

Publication Publication Date Title
AU2003266321A1 (en) Tetrahydropyrimidine-2-one derivatives and their uses
AU2003202263A1 (en) Roh-kinase inhibitors
AU6903200A (en) Heterocycle amides as cell adhesion inhibitors
AU2003284001A1 (en) Triazolone and triazolethione derivatives
AU2003261276A1 (en) Thin film battery
AU2003282478A1 (en) Discount-instrument methods and systems
AU2003303483A1 (en) Ccr8 inhibitors
AU5152100A (en) Substituted beta-alanine derivatives as cell adhesion inhibitors
AU2003300832A1 (en) NF-KappaB INHIBITORS
AU2003263345A1 (en) Sulphonamide derivatives and their use as tace inhibitors
AU6909300A (en) Substituted ureas as cell adhesion inhibitors
AU2003268033A1 (en) Systems and methods for cell preservation
AU2003299883A1 (en) Ccr8 inhibitors
AU2003271437A1 (en) Arylglycine derivatives and their use as glycine transport inhibitors
AU2003235266A1 (en) Thin battery
AU2003249683A1 (en) Nf-:b inhibitors
AU2003278770A1 (en) Electrochemical cells and systems
AU3716499A (en) Substituted diamines and their use as cell adhesion inhibitors
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2003241392A1 (en) Package with pocket and method for making the same
AU2003205558A1 (en) Thioibotenic acid and derivatives thereof
AU2003237201A1 (en) Talking e-book
AU2003230392A1 (en) Beta-secretase inhibitors
AU2003263502A1 (en) Storage
AU2003292720A1 (en) Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 18, NO 33, PAGE(S) 8616 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME DAIICHI SUNTORY PHARMA CO.,LTD., APPLICATION NO. 2003292720, UNDER INID (71) CORRECT THE NAME TO READ DAIICHI SUNTORY PHARMA CO.,LTD.

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase